Ge Healthcare Technologies Inc 's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Ge Healthcare Technologies Inc 's ROA in the third quarter of 2026?
Ge Healthcare Technologies Inc achieved a return on average assets (ROA) of 5.9 % in its third quarter of 2026, this is above GEHC's average return on assets of 5.81%.
Ge Healthcare Technologies Inc s assets during the 12 months ending in the third quarter of 2026 are valued at $37 billion

ROA has improved compared to 5.55% in the second quarter of 2026, due to net income growth.

However, within the Healthcare sector 142 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2026 quarter, so far to 1105, from total ROA ranking in the second quarter of 2026 at 1191.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Total Assets Change	4.56 %	3.29 %	10.54 %	27.78 %	22.27 %
Y / Y Net Income Change	32.54 %	12.2 %	-30.1 %	-18.32 %	-5.31 %
Net Income (TTM) in million	2,189	2,038	1,977	2,154	2,289
Return On Assets (TTM)	5.9 %	5.55 %	5.43 %	6.06 %	6.83 %
GEHC's Total Ranking	# 1105	# 1191	# 936	# 921	# 926
Total Assets (TTM) in million	37,774	36,667	37,125	36,930	36,127
Seq. Total Assets Change	3.02 %	-1.23 %	0.53 %	2.22 %	1.77 %
Seq. Net Income Change	9.63 %	36.5 %	-31.73 %	29.74 %	-7.2 %

GEHC's 5 Years Annual ROA >> Back to GEHC Management Effectiveness >> Compare GEHC ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 8
Sector	# 143
Overall	# 1051

Return On Assets Statistics
High	Average	Low
6.81 %	5.81 %	4.97 %
(Jun 30 2025)		(Dec 31 2023)

News about Ge Healthcare Technologies Inc Return on Assets ROA

Evolving Cancer Care GE HealthCare Unveils Cutting-Edge AI Innovations in Radiation Therapy at ASTRO 2024

As the battle against cancer continues to evolve, advancements in technology play a pivotal role in improving patient outcomes. GE HealthCare, a leading innovator in medical technologies, is set to make significant waves at the American Society for Radiation Oncology (ASTRO) 2024 conference in Washington, DC, where it will showcase its latest AI-enhanced radiation therapy solutions. These groundbreaking innovations promise to not only streamline the radiation therapy workflow for clinicians but also enhance the overall experience and effectiveness for cancer patients.Radiation therapy is a critical component of cancer treatment, with approximately 470,000 patients in the U.S. receiving this form of care annually. Alarmingly, more than half of all cancer patients will undergo some form of radiotherapy during their treatment journey. Given the scale of this intervention, it becomes essential to refine and enhance the processes involved in delivering these therapies.

Financial Statements
Ge Healthcare Technologies Inc 's Assets	$ 37,774 million	GEHC's Balance sheet
Ge Healthcare Technologies Inc 's Income	$ 615 million	Quarterly GEHC's Income Statement
GEHC's Income by Division		See GEHC's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	FY	FY
Y / Y Total Assets Change	28.97 %	2.27 %	-	-	-
Total Assets in million	36,906	28,615	27,980	0	0
Y / Y Net Income Change	5.07 %	27.01 %	-	-	-
Net Income in million	2,154	2,050	1,614	0	0
Annual Return On Assets	5.84 %	7.16 %	5.77 %	-	-

GEHC's 5 Years Annual ROA >> Back to GEHC Management Effectiveness >> Compare GEHC ROA to its Competitors

Comment on GEHC's ROA in the fiscal year ending 2025

In the fiscal year 2025 ROA deteriorated to 5.84 %, despite annual net income growth of 5.07 % to $2,154.00 million, from $2,050.00 million a year ago, as GEHC's assets increase to $36,906.00 million, by 5.07 %.

More Return On Assets Ratios
GEHC's' Return on Assets at Yahoo Finance
Medical Laboratories Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
GEHC's Roa Ratio versus Medical Laboratories Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for GEHC's Competitors
Subscribers only: Roa for Ge Healthcare Technologies Inc 's Suppliers
Subscribers only: Return On Assets for GEHC's Customers

You may also want to know
GEHC's Roi	GEHC's Inventory Turnover Ratio	GEHC's Growth Rates	GEHC's Dividend Comparisons
	GEHC's Profitability Ratios	GEHC's Asset Turnover Ratio	GEHC's Dividend Growth
GEHC's Roe	GEHC's Valuation Ratios	GEHC's Financial Strength Ratios	GEHC's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector	ROA
Krystal Biotech Inc	15.48 %
West Pharmaceutical Services Inc	15.47 %
Dexcom Inc	15.47 %
Intuitive Surgical Inc	14.71 %
Vertex Pharmaceuticals Inc	14.16 %
Neurocrine Biosciences Inc	13.69 %
Illumina Inc	13.43 %
Healthcare Services Group Inc	12.79 %
Kiniksa Pharmaceuticals International Plc	12.64 %
Tenet Healthcare Corp	12.39 %
Hca Healthcare Inc	11.73 %
Carlisle Companies Incorporated	11.72 %
Regeneron Pharmaceuticals Inc	11.50 %
Lantheus Holdings Inc	11.43 %
Msa Safety Inc	11.01 %
Encompass Health Corporation	10.99 %
Inspire Medical Systems inc	10.89 %
Transmedics Group Inc	10.67 %
Bristol myers Squibb Company	10.47 %
Lemaitre Vascular Inc	10.28 %
Bio rad Laboratories Inc	9.88 %
3m Company	9.60 %
Bioventus Inc	9.47 %
Medinotec Inc	8.67 %
Tactile Systems Technology Inc	8.53 %
Penumbra Inc	8.13 %
Johnson and Johnson	8.06 %
Pacific Health Care Organization Inc	7.83 %
Boston Scientific Corporation	7.82 %
Ani Pharmaceuticals Inc	7.77 %

Date modified: 2026-10-29T17:23:44+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.